434 related articles for article (PubMed ID: 16615030)
1. [Medical indications and effectiveness of the pneumococcal conjugate vaccine].
Reinert RR
Laryngorhinootologie; 2006 Apr; 85(4):291-8; quiz 299-300. PubMed ID: 16615030
[TBL] [Abstract][Full Text] [Related]
2. [Value of pneumococcal vaccination in infants and young children].
Adam D; Scholz H
Klin Padiatr; 2001; 213(3):109-13. PubMed ID: 11417363
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal conjugate vaccines--a European perspective.
Reinert RR
Int J Med Microbiol; 2004 Oct; 294(5):277-94. PubMed ID: 15532987
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal conjugate vaccine for young children.
Selman S; Hayes D; Perin LA; Hayes WS
Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
[TBL] [Abstract][Full Text] [Related]
5. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
[TBL] [Abstract][Full Text] [Related]
6. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
[TBL] [Abstract][Full Text] [Related]
8. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines.
von Kries R; Siedler A; Schmitt HJ; Reinert RR
Clin Infect Dis; 2000 Aug; 31(2):482-7. PubMed ID: 10987709
[TBL] [Abstract][Full Text] [Related]
9. Immunisation with a pneumococcal 7-valent conjugate vaccine.
Dagan R
Int J Clin Pract; 2002 May; 56(4):287-91. PubMed ID: 12074212
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?
van Kempen MJ; Vermeiren JS; Vaneechoutte M; Claeys G; Veenhoven RH; Rijkers GT; Sanders EA; Dhooge IJ
Int J Pediatr Otorhinolaryngol; 2006 Feb; 70(2):275-85. PubMed ID: 16140397
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of pneumococcal conjugate vaccination in Australia.
Butler JR; McIntyre P; MacIntyre CR; Gilmour R; Howarth AL; Sander B
Vaccine; 2004 Mar; 22(9-10):1138-49. PubMed ID: 15003641
[TBL] [Abstract][Full Text] [Related]
12. Potential benefits from currently available three pneumococcal vaccines for children--population-based evaluation.
Rückinger S; van der Linden M; Siedler A; von Kries R
Klin Padiatr; 2011 Mar; 223(2):61-4. PubMed ID: 21271500
[TBL] [Abstract][Full Text] [Related]
13. Pneumococcal disease in United States children: prevalence and treatment.
Clanton M
Int J Clin Pract Suppl; 2001 Feb; (118):13-21. PubMed ID: 11715359
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children.
Kilpi T; Ahman H; Jokinen J; Lankinen KS; Palmu A; Savolainen H; Grönholm M; Leinonen M; Hovi T; Eskola J; Käyhty H; Bohidar N; Sadoff JC; Mäkelä PH;
Clin Infect Dis; 2003 Nov; 37(9):1155-64. PubMed ID: 14557958
[TBL] [Abstract][Full Text] [Related]
15. [Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].
de Arístegui Fernández J; Corretger Rauet JM; García Martín F; Hernández-Sampelayo T; Moraga Llop FA; Rodrigo Gonzalo De Liria C; Ruiz Contreras J;
An Esp Pediatr; 2002 Jan; 56(1):79-90. PubMed ID: 11792258
[TBL] [Abstract][Full Text] [Related]
16. Prevention of pneumococcal disease in children. Pneumococcal conjugate vaccines: their use globally could have a major impact on public health.
Kyaw MH; Jones IG; Campbell H
Acta Paediatr; 2001 May; 90(5):473-6. PubMed ID: 11430703
[TBL] [Abstract][Full Text] [Related]
17. [Serious invasive pneumococcal disease in young children: the importance of vaccination].
Haveman LM; Geelen SP; Sanders EA; Wolfs TF
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1917-20. PubMed ID: 12404904
[TBL] [Abstract][Full Text] [Related]
18. Impact of infant immunization programs with pneumococcal conjugate vaccine in Europe.
Rose M; Zielen S
Expert Rev Vaccines; 2009 Oct; 8(10):1351-64. PubMed ID: 19803758
[TBL] [Abstract][Full Text] [Related]
19. Pneumococcal conjugate vaccines: epidemiology guides clinical use.
Heininger U
Klin Padiatr; 2011 Mar; 223(2):59-60. PubMed ID: 21432762
[No Abstract] [Full Text] [Related]
20. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine.
Li ST; Tancredi DJ
Pediatrics; 2010 Jan; 125(1):26-33. PubMed ID: 19948570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]